Michael Halpin
Mike is a strategic global marketer with a proven track record of delivering winning development and launch strategies. His commercial leadership is marked by uncovering and leveraging actionable customer insights which create powerful brands. Mike has experience in leading US and Global teams for brands in development, launching and in market. Mike is currently the Director of Pipeline Commercialization and Strategy for Solid Tumors at AbbVie where he leads commercial development of the c-MET Franchise. Before leading the c-MET Franchise, Mike led the commercial immuno-oncology and PD-1 strategy which received AbbVie’s highest commercial recognition.
Mike started his career in advertising where he learned the value of developing a value proposition based on deep customer insights. After business school Mike went on to commercial roles of increasing responsibility in pharmaceuticals. Starting at Eli Lilly and Company he helped to launch the global blockbuster Cialis and led the Diabetes Business Unit Analytics team. He moved to Shire in 2011 and joined AbbVie in 2014 supporting Solid Tumors in the Oncology Business Unit.
Mike received a BA in History in 1992 from the University of Florida. He enjoys spending time with family, running, collecting wine and attending Chicago Bears games.